JP
BSX icon

John Paulson’s Boston Scientific BSX Stock Holding History

John Paulson’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-288,000
Closed -$6.23M – 101
2016
Q4 		$6.23M Sell
288,000
-122,000
-30% -$2.66M 0.08% 73
2016
Q3 		$9.76M Buy
410,000
+316,000
+336% +$7.54M 0.11% 61
2016
Q2 		$2.2M Buy
94,000
+20,000
+27% +$433K 0.02% 73
2016
Q1 		$1.39M Buy
+74,000
New +$1.3M 0.01% 88

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

John Paulson's BSX Position: Q1 2017 in Review

John Paulson sold out of Boston Scientific (BSX) in Q1 2017, closing a stake of 288,000 shares — an estimated $6.23M sold.

John Paulson first reported a position in BSX in Q1 2016 and held it in 4 quarters. The position peaked at $9.76M in Q3 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

  • John Paulson reported no remaining Boston Scientific position as of Q1 2017 after selling out during the quarter.
  • John Paulson sold 288,000 Boston Scientific shares in Q1 2017, an estimated $6.23M.
  • John Paulson first reported a position in Boston Scientific in Q1 2016 and held it in 4 quarters.
  • John Paulson's Boston Scientific position peaked at $9.76M in Q3 2016.
  • 552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on Paulson & Co's 13F filing for Q1 2017, filed 15 May 2017.